Nuveen Growth Allocation C
Nuveen 333 W. Wacker Drive Chicago, IL 60606
Map
Phone: 800-257-8787
| Category: | World Stock | | Fund Family: | Nuveen | | Net Assets: | 5.39M | | Year-to-Date Return: | -12.16% | | Yield: | 0.07% | | Morningstar Rating: |  | | Fund Inception Date: | 09-Dec-04 |
|
James A. Colon
Lead Manager since
01-Aug-08 | | | Since 2006, Colon has managed the quantitative analysis underlying R&Ts asset allocation, asset liability modeling, manager structuring, alternative investment research and risk management methods. Prior to joining R&T, he was a consultant with Consulting Services Support Corporation from 2000 to 2006. Colon is a member of the CFA Institute, the CFA Society of Chicago and the International Association of Financial Engineers. Colon holds the Chartered Financial Analyst designation. |
| Min Initial Investment: | $3,000 | | Min Initial Investment, IRA: | $1,000 | | Min Initial Investment, AIP: | $50 | | Min Subsequent Investment: | $50 | | Min Subsequent Investment, IRA: | $50 | | Min Subsequent Investment, AIP: | $50 |
|
| |
| The investment seeks long-term total return with a conservative risk profile. The fund is a "fund of funds” that invests principally in shares of other registered investment companies, including open-end mutual funds and exchange-traded funds. The fund's investments are focused in the Underlying funds, so the fund's investment performance is directly related to the performance of the Underlying funds. The Underlying funds, in turn, invest in a variety of U.S. and non-U.S. equity and fixed income securities. The fund has a strategic allocation between equity and fixed income investments that correlates with the fund's risk profile. |
| Last Dividend
(28-Dec-07):
| 0.02 | | Last Cap Gain
(14-Dec-07):
| 1.34 | | Annual Holdings Turnover
| 31.00% | | Average for Category:
| 61.53% |
|
| Expense | NGVCX | Category
Avg | | Total Expense Ratio: | 2.43%
| 1.56% | | Max 12b1 Fee: | 1.00%
| N/A | | Max Front End Sales Load: | 0.00%
| 5.27% | | Max Deferred Sales Load: | 1.00%
| 2.63% | | 3 Yr Expense Projection*: |
$655 | $695 | | 5 Yr Expense Projection*: |
$1,180 | $1,090 | | 10 Yr Expense Projection*: |
$2,639 | $2,150 |
|
|
1.49% Nasdaq 
0.27%
Profile
